Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q3 FY22 results · Oct–Dec 2021
Max Healthcare Institute reported revenue from operations of ₹974.16 crore (up 22.4% from Q3 FY21) and net profit of ₹189.75 crore (up 110.0% from Q3 FY21) for Q3 FY22 (Oct–Dec 2021), on a consolidated basis.
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 974.16 | 795.60 | +22.4% | 1,018.33 | −4.3% |
| Other income | 48.61 | 39.52 | +23.0% | 31.31 | +55.3% |
| Total income | 1,022.77 | 835.12 | +22.5% | 1,049.64 | −2.6% |
| Profit before tax | 213.04 | 104.89 | +103.1% | 181.62 | +17.3% |
| Net profit for the period | 189.75 | 90.36 | +110.0% | 144.65 | +31.2% |
| Attributable to shareholders of the company | 191.02 | 90.36 | +111.4% | 144.65 | +32.1% |
| EPS, basic (₹) | 1.96 | 1.00 | +95.9% | 1.50 | +30.6% |
| Net margin (%) | 19.5 | 11.4 | 14.2 |
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 397.72 | 346.13 | +14.9% | 449.95 | −11.6% |
| Other income | 42.15 | 25.27 | +66.8% | 28.16 | +49.7% |
| Total income | 439.87 | 371.40 | +18.4% | 478.11 | −8.0% |
| Profit before tax | 109.65 | 34.69 | +216.1% | 95.82 | +14.4% |
| Net profit for the period | 103.81 | 31.55 | +229.0% | 73.25 | +41.7% |
| EPS, basic (₹) | 1.07 | 0.35 | not comparable | 0.76 | +40.8% |
| Net margin (%) | 26.1 | 9.1 | 16.3 |
Consolidated
- Filed with BSE
- 12 Feb 2022, 17:09 IST
- Board meeting
- 12 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 Feb 2022, 17:09 IST
- Board meeting
- 12 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE